1. Home
  2. CGEM vs TCBX Comparison

CGEM vs TCBX Comparison

Compare CGEM & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • TCBX
  • Stock Information
  • Founded
  • CGEM 2016
  • TCBX 2008
  • Country
  • CGEM United States
  • TCBX United States
  • Employees
  • CGEM N/A
  • TCBX N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • TCBX Banks
  • Sector
  • CGEM Health Care
  • TCBX Finance
  • Exchange
  • CGEM Nasdaq
  • TCBX Nasdaq
  • Market Cap
  • CGEM 506.1M
  • TCBX 454.9M
  • IPO Year
  • CGEM 2021
  • TCBX 2021
  • Fundamental
  • Price
  • CGEM $7.89
  • TCBX $29.15
  • Analyst Decision
  • CGEM Strong Buy
  • TCBX Hold
  • Analyst Count
  • CGEM 7
  • TCBX 4
  • Target Price
  • CGEM $32.86
  • TCBX $36.67
  • AVG Volume (30 Days)
  • CGEM 520.6K
  • TCBX 81.9K
  • Earning Date
  • CGEM 05-14-2025
  • TCBX 04-23-2025
  • Dividend Yield
  • CGEM N/A
  • TCBX N/A
  • EPS Growth
  • CGEM N/A
  • TCBX 40.59
  • EPS
  • CGEM N/A
  • TCBX 2.78
  • Revenue
  • CGEM N/A
  • TCBX $165,678,000.00
  • Revenue This Year
  • CGEM N/A
  • TCBX $17.61
  • Revenue Next Year
  • CGEM N/A
  • TCBX $6.52
  • P/E Ratio
  • CGEM N/A
  • TCBX $10.48
  • Revenue Growth
  • CGEM N/A
  • TCBX 17.16
  • 52 Week Low
  • CGEM $6.85
  • TCBX $18.26
  • 52 Week High
  • CGEM $30.19
  • TCBX $39.45
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 47.24
  • TCBX 39.80
  • Support Level
  • CGEM $6.93
  • TCBX $26.46
  • Resistance Level
  • CGEM $8.10
  • TCBX $29.32
  • Average True Range (ATR)
  • CGEM 0.52
  • TCBX 2.05
  • MACD
  • CGEM 0.07
  • TCBX -0.04
  • Stochastic Oscillator
  • CGEM 83.20
  • TCBX 46.50

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.

Share on Social Networks: